Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Irritable Bowel Syndrome

  Free Subscription


Articles published in J Gastroenterol Hepatol

Retrieve available abstracts of 42 articles:
HTML format
Text format



Single Articles


    September 2017
  1. GWEE KA, Ghoshal UC, Chen M
    Irritable bowel syndrome in Asia: pathogenesis, natural history, epidemiology and management.
    J Gastroenterol Hepatol. 2017 Sep 13. doi: 10.1111/jgh.13987.
    PubMed     Text format     Abstract available


    August 2017
  2. KHAYYATZADEH SS, Kazemi-Bajestani SMR, Mirmousavi SJ, Heshmati M, et al
    Dietary behaviors in relation to prevalence of irritable bowel syndrome in adolescent girls.
    J Gastroenterol Hepatol. 2017 Aug 2. doi: 10.1111/jgh.13908.
    PubMed     Text format     Abstract available


    July 2017
  3. HEWAWASAM SP, Iacovou M, Muir JG, Gibson PR, et al
    Dietary Practices and Fodmaps in South Asia: Applicability of the Low Fodmap Diet to Patients with Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2017 Jul 12. doi: 10.1111/jgh.13885.
    PubMed     Text format     Abstract available


    June 2017
  4. JIN Y, Ren X, Li G, Li Y, et al
    Rifaximin exerts beneficial effects in PI-IBS mouse model beyond gut microbiota.
    J Gastroenterol Hepatol. 2017 Jun 1. doi: 10.1111/jgh.13841.
    PubMed     Text format     Abstract available


    May 2017
  5. FYSEKIDIS M, Bouchoucha M, Mary F, Airinei G, et al
    Change of appetite in patients with Functional digestive Disorder. Association with psychological disorders: a cross-sectional study.
    J Gastroenterol Hepatol. 2017 May 27. doi: 10.1111/jgh.13836.
    PubMed     Text format     Abstract available


  6. QUACH DT, Hiyama T, Nguyen TA, Ly HQ, et al
    The Asia-Pacific Colorectal Screening Score Is Useful To Stratify Risk for Colorectal Advanced Neoplasms in Vietnamese Patients with Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2017 May 11. doi: 10.1111/jgh.13821.
    PubMed     Text format     Abstract available


    April 2017
  7. NOZU T, Miyagishi S, Kumei S, Nozu R, et al
    A glucagon-like peptide-1 analog, liraglutide improves visceral sensation and gut permeability in rats.
    J Gastroenterol Hepatol. 2017 Apr 25. doi: 10.1111/jgh.13808.
    PubMed     Text format     Abstract available


    March 2017
  8. GIBSON PR
    Use of the low-FODMAP diet in inflammatory bowel disease.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:40-42.
    PubMed     Text format     Abstract available


  9. ANKERSEN DV, Carlsen K, Marker D, Munkholm P, et al
    Using eHealth strategies in delivering dietary and other therapies in patients with irritable bowel syndrome and inflammatory bowel disease.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:27-31.
    PubMed     Text format     Abstract available


  10. IACOVOU M
    Adapting the low FODMAP diet to special populations: infants and children.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:43-45.
    PubMed     Text format     Abstract available


  11. GIBSON PR
    History of the low FODMAP diet.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:5-7.
    PubMed     Text format     Abstract available


  12. WILSON B, Whelan K
    Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:64-68.
    PubMed     Text format     Abstract available


  13. TAN VP
    The low-FODMAP diet in the management of functional dyspepsia in East and Southeast Asia.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:46-52.
    PubMed     Text format     Abstract available


  14. BARRETT JS
    How to institute the low-FODMAP diet.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:8-10.
    PubMed     Text format     Abstract available


  15. GIBSON PR
    The evidence base for efficacy of the low FODMAP diet in irritable bowel syndrome: is it ready for prime time as a first-line therapy?
    J Gastroenterol Hepatol. 2017;32 Suppl 1:32-35.
    PubMed     Text format     Abstract available


  16. GIBSON PR, Skodje GI, Lundin KE
    Non-coeliac gluten sensitivity.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:86-89.
    PubMed     Text format     Abstract available


  17. HALMOS EP
    When the low FODMAP diet does not work.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:69-72.
    PubMed     Text format     Abstract available


  18. VARNEY J, Barrett J, Scarlata K, Catsos P, et al
    FODMAPs: food composition, defining cutoff values and international application.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:53-61.
    PubMed     Text format     Abstract available


  19. TUCK C, Barrett J
    Re-challenging FODMAPs: the low FODMAP diet phase two.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:11-15.
    PubMed     Text format     Abstract available


  20. O'KEEFFE M, Lomer MC
    Who should deliver the low FODMAP diet and what educational methods are optimal: a review.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:23-26.
    PubMed     Text format     Abstract available


  21. MALAKAR S
    Bioactive food chemicals and gastrointestinal symptoms: a focus of salicylates.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:73-77.
    PubMed     Text format     Abstract available


  22. MEANCE S, Giordano J, Chuang E, Schneider H, et al
    Food regulations: low FODMAP labeling and communication goals.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:62-63.
    PubMed     Text format     Abstract available


  23. STAUDACHER HM
    Nutritional, microbiological and psychosocial implications of the low FODMAP diet.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:16-19.
    PubMed     Text format     Abstract available


    February 2017
  24. SAHOO S, Padhy SK
    Cross-cultural and Psychological issues in Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2017 Feb 27. doi: 10.1111/jgh.13773.
    PubMed     Text format     Abstract available


  25. CHOI YJ, Kim N, Yoon H, Shin CM, et al
    Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses.
    J Gastroenterol Hepatol. 2017 Feb 4. doi: 10.1111/jgh.13756.
    PubMed     Text format     Abstract available


  26. HARVIE R, Walmsley R, Schultz M
    "We are what our bacteria eat": The role of bacteria in personalizing nutrition therapy in gastrointestinal conditions.
    J Gastroenterol Hepatol. 2017;32:352-357.
    PubMed     Text format     Abstract available


    November 2016
  27. BAI T, Xia J, Jiang Y, Cao H, et al
    Comparison of the Rome IV and Rome III criteria for IBS diagnosis: a cross-sectional survey.
    J Gastroenterol Hepatol. 2016 Nov 10. doi: 10.1111/jgh.13642.
    PubMed     Text format     Abstract available


    October 2016
  28. LOKTIONOV A, Chhaya V, Bandaletova T, Poullis A, et al
    Inflammatory bowel disease detection and monitoring by measuring biomarkers in non-invasively collected colorectal mucus.
    J Gastroenterol Hepatol. 2016 Oct 27. doi: 10.1111/jgh.13627.
    PubMed     Text format     Abstract available


    September 2016
  29. THORSVIK S, Damas JK, van Beelen Granlund A, Flo TH, et al
    Fecal Neutrophil Gelatinase Associated Lipocalin (NGAL) as a biomarker for Inflammatory Bowel Disease.
    J Gastroenterol Hepatol. 2016 Sep 18. doi: 10.1111/jgh.13598.
    PubMed     Text format     Abstract available


    August 2016
  30. QI Q, Chen F, Zhang W, Wang P, et al
    Colonic N-methyl-D-aspartate receptor contributes to visceral hypersensitivity in irritable bowel syndrome.
    J Gastroenterol Hepatol. 2016 Aug 30. doi: 10.1111/jgh.13588.
    PubMed     Text format     Abstract available


    June 2016
  31. ZHUANG X, Xiong L, Li L, Li M, et al
    Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2016 Jun 14. doi: 10.1111/jgh.13471.
    PubMed     Text format     Abstract available


  32. GHOSHAL UC, Singh R
    Frequency and risk factors of functional gastro-intestinal disorders in a rural Indian population.
    J Gastroenterol Hepatol. 2016 Jun 5. doi: 10.1111/jgh.13465.
    PubMed     Text format     Abstract available


    April 2016
  33. GONZALEZ-CASTRO AM, Martinez C, Salvo-Romero E, Fortea M, et al
    Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2016 Apr 18. doi: 10.1111/jgh.13417.
    PubMed     Text format     Abstract available


    February 2016
  34. YAO X, Yang YS, Cui LH, Sun G, et al
    The overlap of Upper Functional Gastrointestinal disorders with Irritable Bowel Syndrome in Chinese Outpatients: a multi-center study.
    J Gastroenterol Hepatol. 2016 Feb 15. doi: 10.1111/jgh.13317.
    PubMed     Text format     Abstract available


  35. LOBO B, Serra J, D'Amato M, Rovati L, et al
    Effect of selective CCK1 receptor antagonism on accommodation and tolerance of intestinal gas in functional gut disorders.
    J Gastroenterol Hepatol. 2016;31:288-93.
    PubMed     Text format     Abstract available


    January 2016
  36. HSU LT, Hung KY, Wu HW, Liu WW, et al
    Gut-derived cholecystokinin contributes to visceral hypersensitivity via nerve growth factor-dependent neurite outgrowth.
    J Gastroenterol Hepatol. 2016 Jan 15. doi: 10.1111/jgh.13296.
    PubMed     Text format     Abstract available


    December 2015
  37. TADA Y, Ishihara S, Kawashima K, Fukuba N, et al
    Down-regulation of serotonin reuptake transporter gene expression in healing colonic mucosa in presence of remaining low grade inflammation in ulcerative colitis.
    J Gastroenterol Hepatol. 2015 Dec 16. doi: 10.1111/jgh.13268.
    PubMed     Text format     Abstract available


    June 2015
  38. YAO CK, Barrett JS, Philpott H, Chung AR, et al
    Breath hydrogen response after lactulose does not predict symptom response to a probiotic fermented milk product in irritable bowel syndrome.
    J Gastroenterol Hepatol. 2015 Jun 11. doi: 10.1111/jgh.13015.
    PubMed     Text format     Abstract available


    April 2015
  39. YAMAMOTO R, Kaneita Y, Osaki Y, Kanda H, et al
    Irritable bowel syndrome among Japanese adolescents: A nationally representative survey.
    J Gastroenterol Hepatol. 2015 Apr 13. doi: 10.1111/jgh.12974.
    PubMed     Text format     Abstract available


    December 2014
  40. WANG Y, Xiong L, Gong X, Li W, et al
    Small intestinal bacterial overgrowth is an uncommon cause of false positive lactose hydrogen breath test among patients with diarrhoea-predominant irritable bowel syndrome in Asia.
    J Gastroenterol Hepatol. 2014 Dec 3. doi: 10.1111/jgh.12862.
    PubMed     Text format     Abstract available


    August 2014
  41. REY DE CASTRO NG, Miller V, Carruthers HR, Whorwell PJ, et al
    Irritable bowel syndrome: a comparison of subtypes.
    J Gastroenterol Hepatol. 2014 Aug 5. doi: 10.1111/jgh.12704.
    PubMed     Text format     Abstract available


    May 2014
  42. ZHU JZ, Yan TL, Yu CH, Wan XY, et al
    Is national socioeconomic status related to prevalence of irritable bowel syndrome?
    J Gastroenterol Hepatol. 2014 May 29. doi: 10.1111/jgh.12609.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: